课题基金 / 基金详情

HIGH INTENSITY LIGHT THERAPY IN ALZHEIMER'S DISEASE

HIGH INTENSITY LIGHT THERAPY IN ALZHEIMER'S DISEASE
高强度光疗法治疗阿尔茨海默病
批准号:
6791163
负责人:
PHILIP D SLOANE
金额:
$20.88万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-25 至 2004-06-30

项目摘要

项目成果

PHILIP D SLOANE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (APPLICANT'S ABSTRACT): The care of persons with Alzheimer's disease and related dementias (AD) is a prevalent, costly, and growing issue, particularly for long-term care settings, where nearly 1.5 million persons with AD reside. Among the most troublesome management issues in AD are a tried of interrelated problems-sleep/wake disorders, depressive symptoms, and agitation. Current management of these conditions relies extensively on psychoactive medications, which have limited effectiveness and significant adverse effects. Demonstration of an effective, low-risk alternative treatment could have a favorable impact on long-term care nationwide. One promising alternative, high intensity light, has been demonstrated to produce biochemical and physiological effects on the systems that mediate these behaviors, and to have produced significant improvement in pilot and preliminary studies. The proposed project is a clinical trial with crossover, of the effect of high intensity, low glare, ambient daytime light on sleep/wake patterns, depressive symptoms, and agitation in nursing home residents with AD. It will be conducted in a licensed skilled nursing facility within a state psychiatric hospital, which manages 45 residents with AD. It will employ a 4 treatment, 12 period crossover design, with the treatments consisting of a) morning high intensity light, b) evening high intensity light, c) full day high intensity light, and d) the control (preexisting) lighting. The intervention (applied separately to each of 3 wards) will consist of fixtures that produce even, non-glare light averaging 2500-3000 lux in all public areas of the facility. Sleep/activity will be measured using wrist motion sensors; depressive symptoms will be measured using the Cornell Depression Index and the Philadelphia Geriatric Center Affect Rating Scale; and agitation will be measured using computer-assisted direct observations and the Cohen-Mansfield Agitation Inventory. Light exposure will be documented using wrist photocells. Secondary outcomes will include staff depression and reported hassles. Data collection will continue for one year to allow analyses to adjust for seasonal differences in outdoor light levels.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cct.2007.06.004
发表时间: 2008
期刊: Contemporary clinical trials
影响因子: 2.2
作者: [Sloane,Philip, Ivey,Jena, Roth,Mary, Roederer,Mary, Williams,ChristiannaS]
通讯作者: Williams,ChristiannaS
Light as Therapy for Sleep Disorders and Depression in Older Adults.
光疗法治疗老年人的睡眠障碍和抑郁症。
DOI: --
发表时间: 2008
期刊: Clinical geriatrics
影响因子: --
作者: [Sloane,PhilipD, Figueiro,Mariana, Cohen,Lauren]
通讯作者: Cohen,Lauren
Infection Management and Antibiotic Stewardship in Nursing Homes
Infection Management and Antibiotic Stewardship in Nursing Homes
Infection Management and Antibiotic Stewardship in Nursing Homes
Alzheimers Medical Advisor: A Symptom and Sign Management Toolkit for Caregivers
海外基金